Segal-Bendirdjian E - Search Results

1

Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.

Lambert B, Segal-Bendirdjian E, Esnault C, Le Pecq JB, Roques BP, Jones B, Yeung AT. Lambert B, et al. Anticancer Drug Des. 1990 Feb;5(1):43-53. Anticancer Drug Des. 1990. PMID: 2180423

2

Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agent.

Esnault C, Brown SC, Segal-Bendirdjian E, Coulaud D, Mishal Z, Roques BP, Le Pecq JB. Esnault C, et al. Biochem Pharmacol. 1990 Jan 1;39(1):109-22. doi: 10.1016/0006-2952(90)90654-4. Biochem Pharmacol. 1990. PMID: 2297352

3

Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.

Segal-Bendirdjian E, Coulaud D, Roques BP, Le Pecq JB. Segal-Bendirdjian E, et al. Cancer Res. 1988 Sep 1;48(17):4982-92. Cancer Res. 1988. PMID: 2842043

4

Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.

Mailliet P, Segal-Bendirdjian E, Kozelka J, Barreau M, Baudoin B, Bissery MC, Gontier S, Laoui A, Lavelle F, Le Pecq JB, et al. Mailliet P, et al. Anticancer Drug Des. 1995 Jan;10(1):51-73. Anticancer Drug Des. 1995. PMID: 7695813

5

Isolation and characterization of mitochondrial DNA-less lines from various mammalian cell lines by application of an anticancer drug, ditercalinium.

Inoue K, Takai D, Hosaka H, Ito S, Shitara H, Isobe K, LePecq JB, Segal-Bendirdjian E, Hayashi J. Inoue K, et al. Biochem Biophys Res Commun. 1997 Oct 9;239(1):257-60. doi: 10.1006/bbrc.1997.7446. Biochem Biophys Res Commun. 1997. PMID: 9345305

6

Isolation of mitochondrial DNA-less mouse cell lines and their application for trapping mouse synaptosomal mitochondrial DNA with deletion mutations.

Inoue K, Ito S, Takai D, Soejima A, Shisa H, LePecq JB, Segal-Bendirdjian E, Kagawa Y, Hayashi JI. Inoue K, et al. J Biol Chem. 1997 Jun 13;272(24):15510-5. doi: 10.1074/jbc.272.24.15510. J Biol Chem. 1997. PMID: 9182585 Free article.

7

Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives.

Markovits J, Larsen AK, Ségal-Bendirdjian E, Fossé P, Saucier JM, Gazit A, Levitzki A, Umezawa K, Jacquemin-Sablon A. Markovits J, et al. Biochem Pharmacol. 1994 Aug 3;48(3):549-60. doi: 10.1016/0006-2952(94)90285-2. Biochem Pharmacol. 1994. PMID: 8068042

8

Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.

Segal-Bendirdjian E, Jacquemin-Sablon A. Segal-Bendirdjian E, et al. Exp Cell Res. 1995 May;218(1):201-12. doi: 10.1006/excr.1995.1148. Exp Cell Res. 1995. PMID: 7537690

9

[Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis].

Segal-Bendirdjian E, Jacquemin-Sablon A. Segal-Bendirdjian E, et al. Bull Cancer. 1996 May;83(5):371-8. Bull Cancer. 1996. PMID: 8680089 Review. French.

10

Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance.

Ségal-Bendirdjian E, Mannone L, Jacquemin-Sablon A. Ségal-Bendirdjian E, et al. Cell Death Differ. 1998 May;5(5):390-400. doi: 10.1038/sj.cdd.4400357. Cell Death Differ. 1998. PMID: 10200488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters